8-K

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported) October 25, 2007

                             BSD MEDICAL CORPORATION
             (Exact name of registrant as specified in its charter)

        Delaware                      0-10783                75-1590407
 (State or other jurisdiction (Commission File Number)     (IRS Employer
     of incorporation)                                     Identification)


                              2188 West 2200 South
                           Salt Lake City, Utah 84119
          (Address of principal executive offices, including Zip Code)
       Registrant's telephone number, including area code: (801) 972-5555


                                       N/A
          (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

|_|  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

|_|  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

|_|  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

|_|  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

- --------------------------------------------------------------------------------





Item 7.01     Regulation FD Disclosure.

     BSD Medical Corporation issued a press release on October 25, 2007. A copy
of the press release is hereby furnished as Exhibit 99.1 attached hereto.

Item 9.01.     Financial Statements and Exhibits.
(d)            Exhibits
99.1           Press Release of BSD Medical Corporation dated October 25, 2007.


                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused October 25, 2007

                                       By:    /s/  Hyrum A. Mead
                                              ----------------------------------
                                              President






                                  EXHIBIT INDEX

Exhibit No.    Description
- -----------    -----------
99.1           Press Release of BSD Medical Corporation dated
October 25, 2007

EX-99.1

                                                                    Exhibit 99.1

    BSD Medical to Deliver Message of Hope to Largest Conference of
                         Radiation Oncologists

    SALT LAKE CITY--(BUSINESS WIRE)--Oct. 25, 2007--BSD Medical Corp.
(AMEX:BSM) today announced that the company will be exhibiting at the
49th meeting of the largest radiation oncology conference held in
America, the American Society of Therapeutic Radiation and Oncology
(ASTRO), to be held in Los Angeles October 28-31. ASTRO has over 8,500
members, and the attendance for this ASTRO conference is expected to
exceed the 11,000 participants from last year.

    The theme of this year's conference is "Treating Cancer While
Preserving Quality of Life." BSD will deliver a strong message of
hope, based upon the promise of its cancer treatment, consistent with
the theme of the conference.

    In spite of the advances in the treatment of cancer, including the
use of radiation therapy, over 40% of cancer victims continue to die
from the disease. However, when BSD Medical's hyperthermia systems are
used to provide companion treatments to radiation therapy, clinical
trials have shown a significant improvement in both cancer regression
and patient survival for some cancers. These data will be emphasized
at BSD Medical's exhibit, along with a display of the company's cancer
treatment products.

    BSD Medical will also host a workshop session on its therapies
Saturday, October 27, for invited guests from the medical community.
Those speaking will be Dr. David P. Schreiber from Littleton Radiation
Oncology, Dr. Oliver Ott from the University Hospital in Erlangen,
Germany and Dr. Nisar Syed from Long Beach Radiation Oncology Medical
Group.

    BSD Medical Corp. is the leading developer of systems used to
deliver precision-focused hyperthermia therapy for the treatment of
cancer. Hyperthermia therapy is used to destroy cancer cells and
increase the effectiveness of radiation treatments through the
addition of precision-focused heat. For further information about BSD
Medical visit the company's website at www.BSDMedical.com

    Statements contained in this press release that are not historical
facts are forward-looking statements as defined in the Private
Securities Litigation Reform Act of 1995. All forward-looking
statements are subject to risks and uncertainties detailed in the
Company's filings with the Securities and Exchange Commission.

    CONTACT: BSD Medical Corp., Salt Lake City
             Hyrum A. Mead, 801-972-5555
             Fax: 801-972-5930
             Email: investor@bsdmc.com